Press Release

Carmell Announces Successful Closing of $3.0 Million Private Placement
Carmell Announces $3.0 Million Private Placement
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary
Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024
Dr. Leonard Miller joins Carmell SAB
Dr. Bill Kortesis joins Carmell SAB
Dr. Camille Cash joins Carmell SAB
Dr. Gaurav Bharti joins Carmell SAB
Dr. Sean Kelishadi joins Carmell SAB
Dr. Gregory Buford joins Carmell SAB
Dr. Adam Rubinstein joins Carmell SAB
Dr. Jason Bloom joins Carmell SAB
Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors